VILMORIN & CIE financials
VILMORIN & CIE
Country: FR Reporting currency: EUR Latest annual report: 2022-06-30
LEI:
969500TQ4OAZZXSUPZ18 Financial statements
(EUR, as reported — unscaled; 97 line items across 1 annual period)
| Line item | 2022 |
|---|---|
| Income statement | |
| Revenue | €1.59B |
| Cost of sales | €815.7M |
| Operating profit (EBIT) | €136.3M |
| Income tax expense | €25.4M |
| Profit for the year | €95.4M |
| — attributable to owners | €92.2M |
| — attributable to NCI | €3.2M |
| Total comprehensive income | €170.6M |
| Per share | |
| Basic EPS | €4.02 |
| Diluted EPS | €3.98 |
| Free cash flow / share | €10.45 |
| Cash flow statement | |
| Net cash from operating activities | €294.0M |
| Net cash from investing activities | -€253.6M |
| Purchase of PP&E (capex) | €43.5M |
| Purchase of intangibles | €207.6M |
| Net cash from financing activities | -€7.5M |
| Dividends paid | €37.4M |
| Lease liability payments | €26.5M |
| Balance sheet | |
| Total assets | €3.56B |
| Non-current assets | €2.10B |
| Property, plant & equipment | €319.0M |
| Right-of-use assets | €88.0M |
| Intangible assets & goodwill | €455.5M |
| Current assets | €1.46B |
| Inventories | €583.8M |
| Trade & other receivables | €557.7M |
| Cash & equivalents | €321.3M |
| Total equity | €1.48B |
| — attributable to owners | €1.43B |
| Non-controlling interests | €48.8M |
| Non-current liabilities | €1.29B |
| Long-term borrowings | €1.09B |
| Lease liabilities (non-current) | €63.1M |
| Current liabilities | €790.2M |
| Short-term borrowings | €134.1M |
| Lease liabilities (current) | €24.3M |
| Trade & other payables | €587.0M |
| Deferred tax liabilities | €101.0M |
| Derived metrics | |
| Free cash flow | €250.5M |
| Operating margin | 8.6% |
| Net margin | 6.0% |
| Return on equity | 6.4% |
| Cash conversion ratio | 3.08× |
| Capex coverage | 6.76× |
| Other reported items | |
| Adjustments For Decrease Increase In Inventories | -€55.4M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€37.9M |
| Adjustments For Deferred Tax Expense | €2.5M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €255.8M |
| Adjustments For Dividend Income | €0 |
| Adjustments For Fair Value Gains Losses | -€200.0K |
| Adjustments For Finance Income Cost | -€1.4M |
| Adjustments For Increase Decrease In Trade and Other Payables | €43.6M |
| Adjustments For Provisions | -€2.4M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €7.9M |
| Basic Earnings Loss Per Share From Continuing Operations | €4.02 |
| Basic Earnings Loss Per Share From Discontinued Operations | €0.00 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -€100.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | €343.7M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | -€1.3M |
| Comprehensive Income Attributable To Owners of Parent | €171.9M |
| Current Deferred Income Including Current Contract Liabilities | €31.0M |
| Deferred Tax Assets | €30.0M |
| Diluted Earnings Loss Per Share From Continuing Operations | €3.98 |
| Diluted Earnings Loss Per Share From Discontinued Operations | €0.00 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €7.9M |
| Equity and Liabilities | €3.56B |
| General and Administrative Expense | €198.2M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €800.0K |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €2.1M |
| Increase Decrease In Cash and Cash Equivalents | €40.8M |
| Increase Decrease Through Change In Equity of Subsidiaries | €0 |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €300.0K |
| Increase Decrease Through Treasury Share Transactions | €100.0K |
| Intangible Assets Other Than Goodwill | €774.1M |
| Interest Revenue Expense | -€25.4M |
| Investment Accounted For Using Equity Method | €411.5M |
| Issued Capital | €349.5M |
| Noncurrent Financial Assets | €21.4M |
| Noncurrent Provisions For Employee Benefits | €36.3M |
| Other Adjustments To Reconcile Profit Loss | €100.0K |
| Other Comprehensive Income | €75.2M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -€400.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €77.0M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | -€300.0K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €11.9M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €65.7M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €9.5M |
| Other Finance Income Cost | -€8.0M |
| Other Inflows Outflows of Cash Classified As Investing Activities | -€9.3M |
| Other Operating Income Expense | €3.5M |
| Other Shortterm Provisions | €13.8M |
| Profit Loss From Continuing Operations | €95.4M |
| Profit Loss From Discontinued Operations | €0 |
| Research and Development Expense | €227.5M |
| Sales and Marketing Expense | €213.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €17.9M |
Methodology
Every line item above is a fact tagged in VILMORIN & CIE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.